Kumar Emayan is an experienced Laboratory Operations Manager in Discovery Medicinal Chemistry at Exelixis since September 2021. Prior to this role, Kumar held positions at Bayside Pharma as a key start-up member in medicinal chemistry and operations from January 2015 to October 2020, and as a Senior Scientist in Medicinal Chemistry & Drug Discovery at InterMune from June 2011 to January 2015, where significant contributions included the development of anti-fibrotic candidates. Earlier career stages involved leading project initiatives as a Senior Scientist & Project Leader at Nanosyn and as a Scientist at Berlex Biosciences, focused on medicinal chemistry efforts in drug discovery and development. Kumar's educational background includes a PhD in Organic Chemistry from Imperial College London and multiple post-doctoral fellowships, enhancing expertise in chemistry and drug development.
This person is not in any teams
This person is not in any offices